ARRY-371797
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ARRY-371797, covering 2020-10-14 to 2024-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation [Phase 3]